Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805688 · ClinicalTrials.gov registry record
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00805688: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00805688 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00805688 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experience. The study will also use a special telephone system for measuring the symptoms of participants during and after therapy. Your level of physical activity will also be studied using a pedometer and study diary.
Interventions
- BEHAVIORAL Questionnaires
- DEVICE Pedometer
- PROCEDURE Blood Draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-11-12 |
| Est. Completion | 2018-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00805688
The ClinicalTrials.gov registry entry for NCT00805688 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT00805688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00805688 about?
NCT00805688 is a clinical study titled "Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer". The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experien...
What is the current status of trial NCT00805688?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-11-12. Estimated completion is 2018-02-27.
What interventions are being tested in trial NCT00805688?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Pedometer (DEVICE), Blood Draws (PROCEDURE).
Who is sponsoring clinical trial NCT00805688?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.